The first three coronavirus vaccines earned Emergency Use Authorization more than a year ago. To date, no other vaccines have been put into use in the U.S—but that will soon change. More than 40 vaccines are undergoing ...
May 5, 2022
0
119
A team of biophysicists reports that SARS-CoV-2 can withstand large physical forces, which could be one of the reasons for its success. In the scientific journal PNAS, the researchers, led by Prof. Jan Lipfert, who recently ...
May 3, 2022
0
79
A method for delivering genetic material to the body is being tested as a way to repair damaged heart muscle after a heart attack. The ground-breaking research is presented today at Frontiers in CardioVascular Biomedicine ...
May 2, 2022
0
22
Chronic lymphocytic leukemia (CLL) is one of the most common blood cancers in adults. The disease originates in B cells—the part of the immune system that produces antibodies—and then evolves slowly, typically affecting ...
Apr 21, 2022
0
38
A new study compares the regenerative potential of blood/bone marrow aspirate concentrates obtained from arterial blood, venous blood, and bone marrow aspirate. The study, conducted in rabbits, is reported in the peer-reviewed ...
Apr 18, 2022
0
21
It seems every few weeks we hear about a new COVID variant, and it's hard to know how concerned we ought to be.
Apr 14, 2022
0
21
A new study from researchers at the Center for Cell and Gene Therapy at Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital shows that cancer patients who receive treatment with genetically ...
Mar 30, 2022
0
64
It may not feel like it when you're swabbing your throat, but improving how we test for diseases is one of the big positives of COVID. Applying methods developed for COVID to other diseases could revolutionise how we detect ...
Mar 23, 2022
0
2
Using mRNA technology like that in the COVID-19 vaccines, researchers have demonstrated a successful way to deliver a potential HIV vaccine, researchers at Duke Human Vaccine Institute report.
Mar 16, 2022
0
173
SARS-CoV-2 viruses can hide from recognition by the immune system. However, the antiviral immune receptor RIG-I can be stimulated, which improves protection against lethal SARS-CoV-2 infections. Researchers led by Prof. Dr. ...
Mar 8, 2022
5
31
